Sodium channel protein type 1 subunit alpha
Also known as: NAC1, SCN1, SCN1A
Function
Pore-forming subunit of Nav1.1, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na(+) ions provokes membrane depolarization, initiating the propagation of electrical signals throughout cells and tissues. By regulating the excitability of neurons, ensures that they respond appropriately to synaptic inputs, maintaining the balance between excitation and inhibition in brain neural circuits (By similarity). Nav1.1 plays a role in controlling the excitability and action potential propagation from somatosensory neurons, thereby contributing to the sensory perception of mechanically-induced pain (By similarity).
Classification
- Family (Pfam)
- PF00520 Ion_trans, PF24609 IQ_SCN5A_C, PF06512 Na_trans_assoc, PF11933 Na_trans_cytopl
- InterPro
- Ion_trans_dom, IQ_SCN5A_C, Na_channel_a1su, Na_channel_asu, Na_chnl_inactivation_gate, Na_trans_assoc_dom, Na_trans_cytopl, VGCC_Ca_Na, Volt_channel_dom_sf
- Functional cluster
- DEAD-Box RNA Helicases & Biogenesis Factors
Experimental structures · PDB · 1
- 7DTD EM 3.30A
A predicted model is available from AlphaFold.
Gene Ontology · 15
- GO:0043194 axon initial segment
- GO:0014704 intercalated disc
- GO:0043025 neuronal cell body
- GO:0033268 node of Ranvier
- GO:0005886 plasma membrane
- GO:0030315 T-tubule
- GO:0001518 voltage-gated sodium channel complex
- GO:0030018 Z disc
- GO:0099508 voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential
- GO:0005248 voltage-gated sodium channel activity
- GO:0086002 cardiac muscle cell action potential involved in contraction
- GO:0050966 detection of mechanical stimulus involved in sensory perception of pain
- GO:0086010 membrane depolarization during action potential
- GO:0035725 sodium ion transmembrane transport
- GO:0006814 sodium ion transport
Disease associations
- generalized epilepsy with febrile seizures plus, type 2 MONDO:0011461
- developmental and epileptic encephalopathy, 6A MONDO:0100079
- migraine, familial hemiplegic, 3 MONDO:0012320
- developmental and epileptic encephalopathy 6B MONDO:0030268
Drugs targeting this protein · 55
- OXCARBAZEPINE blocker
- CARBAMAZEPINE blocker
- ETHOTOIN blocker
- PRILOCAINE blocker
- MORICIZINE HYDROCHLORIDE blocker
- INDECAINIDE HYDROCHLORIDE blocker
- ORPHENADRINE CITRATE blocker
- LIDOCAINE HYDROCHLORIDE blocker
- QUINIDINE GLUCONATE blocker
- MEPIVACAINE HYDROCHLORIDE blocker
- PROPARACAINE HYDROCHLORIDE blocker
- DYCLONINE HYDROCHLORIDE blocker
- PRILOCAINE HYDROCHLORIDE blocker
- ETIDOCAINE HYDROCHLORIDE blocker
- MEXILETINE HYDROCHLORIDE blocker
- BENOXINATE HYDROCHLORIDE blocker
- HEXYLCAINE HYDROCHLORIDE blocker
- TOCAINIDE HYDROCHLORIDE blocker
- ARTICAINE HYDROCHLORIDE blocker
- PROCAINE HYDROCHLORIDE blocker
- DISOPYRAMIDE PHOSPHATE blocker
- PHENAZOPYRIDINE HYDROCHLORIDE blocker
- ORPHENADRINE HYDROCHLORIDE blocker
- PROPAFENONE HYDROCHLORIDE blocker
- DRONEDARONE HYDROCHLORIDE blocker
- RUFINAMIDE blocker
- TETRACAINE HYDROCHLORIDE blocker
- PHENYTOIN blocker
- PHENYTOIN SODIUM blocker
- PROPOXYCAINE HYDROCHLORIDE blocker
- ROPIVACAINE HYDROCHLORIDE blocker
- ENCAINIDE HYDROCHLORIDE blocker
- NERISPIRDINE blocker
- RALFINAMIDE blocker
- TOPIRAMATE blocker
- IRAMPANEL blocker
- ESLICARBAZEPINE blocker
- DICHLOROBENZYL ALCOHOL blocker
- EVENAMIDE blocker
- QUINIDINE SULFATE blocker
- CENOBAMATE inhibitor
- COCAINE HYDROCHLORIDE blocker
- LACOSAMIDE blocker
- PROCAINAMIDE HYDROCHLORIDE blocker
- TETRACAINE blocker
- LAMOTRIGINE blocker
- RILUZOLE blocker
- ZONISAMIDE blocker
- LIDOCAINE blocker
- PRIMIDONE blocker
- MEPHENYTOIN blocker
- ESLICARBAZEPINE ACETATE blocker
- PHENACEMIDE blocker
- FOSPHENYTOIN SODIUM blocker
- CHLOROPROCAINE HYDROCHLORIDE blocker
Neighborhood · nearest proteins
Related proteins · sequence + function similarity
- Sodium channel protein type 1 subunit alpha 1.00
- Sodium channel protein type 1 subunit alpha 1.00
- Sodium channel protein type 2 subunit alpha 0.98
- Sodium channel protein type 2 subunit alpha 0.98
- Sodium channel protein type 2 subunit alpha 0.98
- Sodium channel protein type 9 subunit alpha 0.98
- Sodium channel protein type 9 subunit alpha 0.98
- Sodium channel protein type 9 subunit alpha 0.98
- Sodium channel protein type 9 subunit alpha 0.97
- Sodium channel protein type 3 subunit alpha 0.97
- Sodium channel protein type 3 subunit alpha 0.97
- Sodium channel protein type 3 subunit alpha 0.97
Co-cited proteins · studied together in the literature
- Sodium channel protein type 2 subunit alpha 16 shared papers
- Sodium channel regulatory subunit beta-1 3 shared papers
- Sodium channel regulatory subunit beta-4 1 shared papers
- Fibroblast growth factor 13 1 shared papers
- Gamma-aminobutyric acid receptor subunit beta-3 3 shared papers
- Phospholipid phosphatase-related protein type 4 1 shared papers
- Phospholipid phosphatase-related protein type 4 1 shared papers
- Sodium channel protein type 5 subunit alpha 2 shared papers
- Sodium channel protein type 3 subunit alpha 2 shared papers
- Syntaxin-binding protein 1 5 shared papers
- Beta/delta-theraphotoxin-Pre1a 1 shared papers
- Sodium channel protein type 8 subunit alpha 7 shared papers
Literature · 96 cited papers
- Functional characteristics of the Nav1.1 p.Arg1596Cys mutation associated with varying severity of epilepsy phenotypes. Int. J. Mol. Sci. · 2024
- Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. Nat. Commun. · 2023
- Mutations in plasticity-related-gene-1 (PRG-1) protein contribute to hippocampal seizure susceptibility and modify epileptic phenotype. Cereb. Cortex · 2023
- Comparative structural analysis of human Nav1.1 and Nav1.5 reveals mutational hotspots for sodium channelopathies. Proc. Natl. Acad. Sci. U.S.A. · 2021
- De novo mutations in the GTP/GDP-binding region of RALA, a RAS-like small GTPase, cause intellectual disability and developmental delay. PLoS Genet. · 2018
- Not all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotype. Neurology · 2017
- A mutation in GABRB3 associated with Dravet syndrome. Am. J. Med. Genet. A · 2017
- The tarantula toxin beta/delta-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity. Sci. Rep. · 2017
- Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes. Hum. Mutat. · 2017
- Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis. J. Med. Genet. · 2016
- Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. Neuron · 2015
- Missense mutations in sodium channel SCN1A and SCN2A predispose children to encephalopathy with severe febrile seizures. Epilepsy Res. · 2015
- … and 84 more in the literature graph